
MLN 3897
CAS No. 1010731-97-1
MLN 3897 ( AVE 9897 )
产品货号. M10069 CAS No. 1010731-97-1
MLN 3897 是一种有效、特异性和口服活性的 CCR1 拮抗剂,在竞争结合测定中 IC50 为 0.8 nM。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥3637 | 有现货 |
![]() ![]() |
10MG | ¥5468 | 有现货 |
![]() ![]() |
25MG | ¥9347 | 有现货 |
![]() ![]() |
50MG | ¥13997 | 有现货 |
![]() ![]() |
100MG | ¥21020 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称MLN 3897
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述MLN 3897 是一种有效、特异性和口服活性的 CCR1 拮抗剂,在竞争结合测定中 IC50 为 0.8 nM。
-
产品描述MLN 3897 is a potent, specific and orally active antagonist of CCR1 with IC50 of 0.8 nM in competition binding assays, 500-fold selectivity over CCR5; inhibits osteoclastogenesis and OC activity by impairing multinucleation and by down-regulation of c-fos signaling, inhibits osteoclastogenesis and OC activity by impairing multinucleation and by down-regulation of c-Fos signaling; demonstrates potential for the treatment of multiple sclerosis and rheumatoid arthritis.Multiple Sclerosis Phase 1 Discontinued.
-
体外实验——
-
体内实验——
-
同义词AVE 9897
-
通路GPCR/G Protein
-
靶点Chemokine Receptor
-
受体Chemokine Receptor
-
研究领域Inflammation/Immunology
-
适应症Multiple Sclerosis
化学信息
-
CAS Number1010731-97-1
-
分子量535.125
-
分子式C32H39ClN2O3
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESO[C@@]1(C2=CC=C(Cl)C=C2)C(C)(C)CN(CC/C=C3C(C=CCN4)=C4COC5=CC=C(C(C)(O)C)C=C\35)CC1
-
化学全称(S,E)-4-(4-chlorophenyl)-1-(3-(7-(2-hydroxypropan-2-yl)-2,11-dihydrobenzo[6,7]oxepino[3,4-b]pyridin-5(1H)-ylidene)propyl)-3,3-dimethylpiperidin-4-ol
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Gilchrist A, et al. Br J Pharmacol. 2014 Nov;171(22):5127-38.
2. Vallet S, et al. Blood. 2007 Nov 15;110(10):3744-52.
3. Lu C, et al. J Pharmacol Exp Ther. 2010 Feb;332(2):562-8.
4. Vergunst CE, et al. Arthritis Rheum. 2009 Dec;60(12):3572-81.